Skip to main content

TRANSCAT INC. Value Stock - Dividend - Research Selection


ISIN: US8935291075 , WKN: 923106

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to integrate and manage the workflow of its calibration service centers and customers\' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as an off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment distributes approximately 100,000 test, measurement, and control instruments for customers\' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Transcat (NASDAQ:TRNS) shareholders have earned a 35% CAGR over the last five years

While Transcat, Inc. ( NASDAQ:TRNS ) shareholders are probably generally happy, the stock hasn't had particularly good...

Insider Sell: President and CEO Lee Rudow Sells 6,000 Shares of Transcat Inc (TRNS)

Transcat Inc (NASDAQ:TRNS), a leading provider of accredited calibration, repair, inspection, and laboratory instrument services, has recently witnessed a significant insider sell by its President and CEO, Lee Rudow.

Reasons for the Outperformance of Transcat (TRNS)

Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […]

Conestoga Capital Advisors Q3 2023 Commentary

Conestoga’s four primary investment strategies posted mixed results for the quarter. Click here to read the full fund letter.

Craig-Hallum Sticks to Their Buy Rating for Transcat (TRNS)

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Transcat: Might Be The Right Time To Exit

TRNS reports strong revenue growth in Q2 FY24 due to life science market demand, but technical analysis predicts a 19% potential downside.

Transcat, Inc. (NASDAQ:TRNS) Q2 2024 Earnings Call Transcript

Transcat, Inc. (NASDAQ:TRNS) Q2 2024 Earnings Call Transcript October 31, 2023 Operator: Greetings welcome to Transcat Inc’s Second Quarter Fiscal 2024 Financial Results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the […]

Some Investors May Be Worried About Transcat's (NASDAQ:TRNS) Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...

Why Global Industrial Co's Stock Skyrocketed 13% in a Quarter

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Q2 2024 Transcat Inc Earnings Call

Q2 2024 Transcat Inc Earnings Call